HPLC-APCI-MS for the determination of vitamin K(1) in human plasma: method and clinical application

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Nov 15;875(2):541-5. doi: 10.1016/j.jchromb.2008.10.009. Epub 2008 Oct 14.

Abstract

A sensitive HPLC-APCI-MS method for the determination of vitamin K(1) (VK-1) in human plasma was established. Target ions at [M+H](+)m/z 451.5 for VK-1 and [M+H](+)m/z 331.4 for the I.S. (teprenone). Calibration curve was linear over the range of 0.3-1,000 ng/ml. The lower limit of quantification was 0.3 ng/ml. The intra- and inter-batch variability values were less than 8% and 15%, respectively. The C(max) was 210.1+/-86.7 ng/ml while the elimination half-life (t(1/2)) was 8.8+/-1.7h and time to the C(max) was 5.5+/-0.8h after administration of soft capsule containing 10mg VK-1.

MeSH terms

  • Administration, Oral
  • Analysis of Variance
  • Chromatography, High Pressure Liquid / methods*
  • Drug Stability
  • Humans
  • Linear Models
  • Male
  • Mass Spectrometry / methods*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Vitamin K 1 / administration & dosage
  • Vitamin K 1 / analogs & derivatives
  • Vitamin K 1 / blood*
  • Vitamin K 1 / pharmacokinetics

Substances

  • Vitamin K 1